Painful motion around the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints is often precipitated by conditions such as arthritis, neuromuscular diseases, trauma, connective tissue disorder, and biomechanical instability, which can interfere with daily activities. This is generally addressed using conservative methods including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs). Digit replacement is a surgical procedure mainly performed to relieve pain and restore function by replacing damaged joint surfaces with artificial implants. The major risk factors that contribute to digit replacement are osteoarthritis and rheumatoid arthritis resulting from old age.
Digit replacement is an intervention indicated for dysfunction of the finger joint due to trauma or arthritis. It is a substitute to arthrodesis when joint pain begins to interfere with daily activities and other medical management routes fail to provide relief. The procedure is complicated and there is a steep learning curve to competency as low procedure numbers prevent surgeons from getting enough hands-on experience. The goal of digit arthroplasty is to relieve pain, fix deformities and maintain the function and appearance of the fingers. Compared to other arthroplasties, the market share of digit replacement is paltry and therefore its addition to a company’s portfolio is normally a strategic business decision.
The Asia-Pacific (APAC) digit replacement market was estimated at US$0.8M in 2016 across the APAC markets (Australia, China, India, Japan, New Zealand, South Korea, and Taiwan) covered in this report. By the end of the forecast period in 2023, it is estimated that the market will grow to approximately US$1.2M at a Compound Annual Growth Rate (CAGR) of 6%.
Key drivers of the digit replacement market in the forecast period are -
- The aging population and rising prevalence of arthritis
- Materials research into more durable and biocompatible implants
- Long-term results that showcase the benefits of digit arthroplasty compared to alternative treatments.
The APAC digit replacement market is projected to grow at a CAGR of 6% during the forecast period. Australia represented the largest portion of the market in 2016, holding nearly 25% of the regional revenue, though it is expected to be surpassed by China during the forecast period. China is expected to be the fastest-growing country in the APAC and global market through 2023, at a CAGR of 17%, while the slowest growth will be observed in Japan, New Zealand, and Taiwan at CAGRs of 0%.
The market for digit replacement is divided into two product categories: silicone and pyrolytic-based implants. The most popular finger implant is the silicone-based Swanson prosthesis, the gold standard upon which several silicone finger joint prostheses designs are based. Other players in this market include Integra LifeSciences, Stryker, Wright Medical, Zimmer Biomet, and Depuy Orthopedics.
The report "MediPoint: Digit Replacement - APAC Analysis and Market Forecasts", focuses on the market outlook for digit replacement devices in Asia-Pacific (APAC: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan). The analysis identifies the key unmet needs in the digit replacement market, discusses the major drivers and barriers of adoption, and provides an in-depth understanding of physicians’ perceptions and the future outlook for this market by segment and geography.
Companies mentioned in this report: Integra LifeSciences, Stryker, Wright Medical, Zimmer Biomet, Depuy Orthopaedics.
- Overview of recent key industry events and analysis of their market impact.
- Annualized total market revenue, procedure trends, and market outlooks by segment and by region through 2023.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.
- Analysis of the current and future market competition in the global digit replacement market. Insightful review of industry drivers, barriers, and challenges.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Key Metrics
2.2 Market Dynamics
2.3 Key Players
2.4 Future Outlook
2.5 What Do Physicians Think?
3.2 Related Reports
3.3 Upcoming Related Reports
4 Market Outlook
4.1 Procedure Trends
4.2 Pricing Trends
4.3 Revenue Trends
4.4 Company Share Analysis
5 Market Insights
5.1.1 Australia & New Zealand
5.1.2 China & Taiwan
5.1.5 South Korea
6 Competitive Assessment
6.2 Integra LifeSciences
6.2.1 Portfolio Assessment
6.2.2 Deal Analysis
6.2.3 Competitive Positioning
6.3.1 Portfolio Assessment
6.3.2 Deal Analysis
6.3.3 Competitive Positioning
6.4 Wright Medical
6.4.1 Portfolio Assessment
6.4.2 Deal Analysis
6.4.3 Competitive Positioning
6.5 Zimmer Biomet
6.5.1 Portfolio Assessment
6.5.2 Deal Analysis
6.5.3 Competitive Positioning
6.6 Depuy Orthopaedics
6.6.1 Portfolio Assessment
6.6.2 Deal Analysis
6.6.3 Competitive Positioning
6.7 Other Players
7.3.3 Secondary Research
7.3.4 Forecasting Methodology
7.3.5 Primary Research Summary
7.4 About the Authors
7.4.2 Global Head of Medical Devices
7.5 About MediPoint
7.6 About the Publisher
7.7 Contact Us
1.1 List of Tables
Table 1: Key Metrics in the APAC Markets
Table 2: APAC Procedure Volume Forecast, 2014-2023
Table 3: APAC Average Selling Price Forecast, 2014-2023
Table 4: APAC Sales Forecast ($M), 2014-2023
Table 5: APAC Company Share Analysis, 2016
Table 6: Integra LifeSciences - Key Marketed Products Assessment
Table 7: Integra LifeSciences - Key Clinical Trials
Table 8: Stryker - Key Marketed Products Assessment
Table 9: Wright Medical - Key Marketed Products Assessment
Table 10: Zimmer Biomet Medical - Key Marketed Products Assessment
Table 11: Depuy Orthopaedics Medical - Key Marketed Products Assessment
Table 12: Summary of Other Players in the Market, 2017
1.2 List of Figures
Figure 1: APAC Sales for Digit Replacement by Country, 2016 and 2023